News Focus
News Focus
icon url

Jasbg

10/03/20 4:46 PM

#302888 RE: lizzy241 #302887

lizzy@ You are referring to this:

https://www.hikma.com/media/2836/vascepa-statement-september-2020-vfinal.pdf

Vascepa®
is a prescription medicine that is indicated, in part, as an adjunct to diet to reduce triglyceride
levels in adult patients with severe (= 500 mg/dL) hypertriglyceridemia. According to IQVIA, US sales of
Vascepa® were approximately $1.1 billion in the 12 months ending July 2020.



We have to remember that little 'One Drug' Amarin - are up against Giants here - Hikma and Dr. Reddy - for whom these ANDA Lawsuit's are 'what they do' all year around.

https://www.hikma.com/products/

690 Products (roll down the site)

Win over Amarin - bringing Vascepa to line of products - a small notice on the frontpage.

https://www.hikma.com/home/
icon url

Cardiologymd

10/03/20 4:46 PM

#302889 RE: lizzy241 #302887

“Today’s decision demonstrates Hikma’s ability to successfully challenge patents on important
medicines and to provide value to our customers and millions of patients across the United States “

I doubt there are millions of patients with trig above 500. The condition is rare.
icon url

ziploc_1

10/03/20 5:49 PM

#302896 RE: lizzy241 #302887

This Hickma PR makes it plain what the intent of Hickma is...i.e.to effect a monster number of sales with Generic Vascepa...which can only be done through inducing infringement on Amarin's Reduce-It patents patents for CVD.

If you brandish a weapon and say you can shoot someone with it, do you have to wait until a person is shot before you intercede?
icon url

dukesking

10/03/20 9:07 PM

#302925 RE: lizzy241 #302887

This proves their intent to infringe on non marine scripts. They feel emboldened and free to state that they will knowingly be treating millions of patients and take a huge chunk of this 1.1 billion in sales. They admit that they are ramping up supply to meet the demand. They believed they won and are now untouchable regarding infringement because they thought it would only be perpetrated by the doctors, insurers, pharmacies, PBM’s and the states that require a switch to generics. Think again Hikma. You knowingly admit that you intend to infringe and if you supply beyond the marine indication market, you’ll pay!! Go to hell you scumbags!!!